Ocugen officer proposes $498K common share sale

The notice places the proposed sale against 339,110,401 shares outstanding and reports prior sales by Musunuri and KVM Holdings LLC.

Rhea-AI Filing Summary

Ocugen, Inc. officer Shankar Musunuri reported a proposed sale of 525,991 common shares through Merrill Lynch, with an aggregate market value of $497,964.91 and an approximate sale date of October 9, 2026. The notice also lists September 9, 2026 sales of 468,727 common shares by Musunuri and 57,264 common shares by KVM Holdings LLC.

Key Figures

Common shares proposed for sale: 525,991 shares Aggregate market value: $497,964.91 Common shares outstanding: 339,110,401 shares +4 more

7 metrics

Common shares proposed for sale 525,991 shares Approximate sale date: October 9, 2026

Aggregate market value $497,964.91 Proposed sale

Common shares outstanding 339,110,401 shares Reported in the notice

Common shares sold by Shankar Musunuri 468,727 shares September 9, 2026

Reported sale value for Shankar Musunuri $525,536.71 September 9, 2026

Common shares sold by KVM Holdings LLC 57,264 shares September 9, 2026

Reported sale value for KVM Holdings LLC $64,204.39 September 9, 2026

Key Terms

Rule 144, Equity Compensation, Securities To Be Sold

3 terms

Rule 144 regulatory

"paragraph (e) of Rule 144 to be aggregated"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Equity Compensation financial

"Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

Securities To Be Sold regulatory

"Securities To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is the proposed OCGN share sale, and which broker is named?

The notice lists an approximate sale date of October 9, 2026, and names Merrill Lynch as broker for 525,991 common shares with an aggregate market value of $497,964.91.

What prior OCGN share sales are listed?

The notice lists September 9, 2026 sales of 468,727 common shares by Shankar Musunuri, valued at $525,536.71, and 57,264 common shares by KVM Holdings LLC, valued at $64,204.39.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/09/2026 - 06:16 PM Accepted by SEC EDGAR 10/09/2026 - 06:15 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001791820
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Ocugen, Inc.
SEC File Number	001-36751
Address of Issuer	11 Great Valley Parkway Malvern PENNSYLVANIA 19355
Phone	4843284701
Name of Person for Whose Account the Securities are To Be Sold	Shankar Musunuri
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 4 Penn Center - 1600 JFK Blvd Philadelphia PA 19103	525991	497964.91	339110401	10/09/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/03/2025	Equity Compensation	Issuer			388701	01/03/2025	Equity Compensation
Common	01/03/2024	Equity Compensation	Issuer			80026	01/03/2024	Equity Compensation
Common	02/10/2014	Equity Compensation	Issuer			57264	02/10/2014	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Shankar Musunuri 11 Great Valley Parkway Malvern PA 19355	Common	09/09/2026	468727	525536.71
KVM Holdings LLC 11 Great Valley Parkway Malvern PA 19355	Common	09/09/2026	57264	64204.39

144: Remarks and Signature

Remarks	Shares sold via Shankar Musunuri, Individually and via KVM holdings
Date of Notice	10/09/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/05/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Shankar Musunuri
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)